Prognostic Factors on Overall Survival of Newly Diagnosed Metastatic Nasopharyngeal Carcinoma
Authors:
- Shao-Min HuangSHShao-Min Huang
- Bi-Xiu WenBWBi-Xiu Wen
- Tai-Xiang LuTLTai-Xiang Lu
Open Access
- 1 April 2014
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (7) , 3169-3173
Abstract
To investigate factors associated with overall survival in patients with newly diagnosed metastatic nasopharyngeal carcinoma. Two hundred and two consecutive patients with pathologically confirmed nasopharyngeal carcinoma with distant metastasis at diagnosis seen between December 2007 and May 2011 were reviewed. Patient, tumor and treatment factors were analyzed for their significance regarding overall survival. The median follow-up time was 22 months. At the time of this report, 116 patients had died. For 112 patients, cause of death was nasopharyngeal carcinoma. The 1, 2, 3, and 4-year overall survival rates were 75.6%, 50.2%, 39.2%, and 28.2%, respectively. Cox regression multivariate analysis showed that T-stage (p=0.045), N-stage (p=0.014), metastasis number (p<0.001) and radiotherapy for nasopharynx and neck (p<0.001) were significant factors for overall survival. Early T-stage and N-stage, solitary metastasis in a single organ were good prognostic factors for patients with newly diagnosed metastatic nasopharyngeal carcinoma. Radiotherapy should be strongly recommended in systemic treatment.Keywords
This publication has 19 references indexed in Scilit:
- Triplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinomaCancer Chemotherapy and Pharmacology, 2012
- Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?BMC Cancer, 2011
- Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation TherapyJapanese Journal of Clinical Oncology, 2011
- Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinomaActa Oto-Laryngologica, 2008
- Les cancers métastatiques du nasopharynx : étude clinique et résultats thérapeutiques de 95 casCancer/Radiothérapie, 2006
- Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaJournal of Clinical Oncology, 2005
- Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volumeCancer, 2004
- Long-Term Disease-Free Survivors in Metastatic Undifferentiated Carcinoma of Nasopharyngeal TypeJournal of Clinical Oncology, 2000
- The tumor voluem and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomographyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992